The diminished IL-17A response in higher-grade tumors may reflect immune suppression or altered cytokine signaling in more advanced disease states, highlighting the interconnected roles of IL-8, IL-17A, and IL-33 in colorectal cancer. This evidence concerns the gene IL17A and colorectal cancer.